Abstract:Abstract Digital analysis of pathology whole-slide images is fast becoming a game changer in cancer diagnosis and treatment. Specifically, deep learning methods have shown great potential to support pathology analysis, with recent studies identifying molecular traits that were not previously recognized in pathology H&E whole-slide images. Simultaneous to these developments, it is becoming increasingly evident that tumor heterogeneity is an important determinant of cancer prognosis and susceptibility to treatment, and should therefore play a role in the evolving practices of matching treatment protocols to patients. State of the art diagnostic procedures, however, do not provide automated methods for characterizing and/or quantifying tumor heterogeneity, certainly not in a spatial context. Further, existing methods for analyzing pathology whole-slide images from bulk measurements require many training samples and complex pipelines. Our work addresses these two challenges. First, we train deep learning models to spatially resolve bulk mRNA and miRNA expression levels on pathology whole-slide images (WSIs). Our models reach up to 0.95 AUC on held-out test sets from two cancer cohorts using a simple training pipeline and a small number of training samples. Using the inferred gene expression levels, we further develop a method to spatially characterize tumor heterogeneity. Specifically, we produce tumor molecular cartographies and heterogeneity maps of WSIs and formulate a heterogeneity index (HTI) that quantifies the level of heterogeneity within these maps. Applying our methods to breast and lung cancer slides, we show a significant statistical link between heterogeneity and survival. Our methods potentially open a new and accessible approach to investigating tumor heterogeneity and other spatial molecular properties and their link to clinical characteristics, including treatment susceptibility and survival.

Breaks for Precision Medicine in Cancer: Development and Prospects of Spatiotemporal Transcriptomics

Spatial transcriptomics: a new frontier in accurate localization of breast cancer diagnosis and treatment

Advances in spatial transcriptomics and its applications in cancer research

Spatially resolved transcriptomics provide a new method for cancer research

Spatial transcriptomics: a new frontier in cancer research

A Guidebook of Spatial Transcriptomic Technologies, Data Resources and Analysis Approaches

Advances in Spatial Transcriptome Technologies

Novel insights from spatial transcriptome analysis in solid tumors

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

Advances in spatial multi-omics in tumors

A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology.

Spatial Transcriptomics Technology in Cancer Research.

Spatial Transcriptomics for Tumor Heterogeneity Analysis

Technique Integration of Single-Cell RNA Sequencing with Spatially Resolved Transcriptomics in the Tumor Microenvironment

Spatially Resolved Transcriptomics Technology Facilitates Cancer Research

Spatial transcriptomics in human biomedical research and clinical application

Spatial transcriptomics in pancreatic cancer: Advances, prospects and challenges

Advances in spatial transcriptomics and related data analysis strategies

The spatial multi-omics revolution in cancer therapy: Precision redefined

Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era